ISPE Tampa Tampa Conference 22-25 February 2010 Tampa, Florida Fl orida USA
Au A u t o m ated at ed Vis Vi s u al Ins In s p ect ec t i o n o f Pre-filled Pre-filled Syringes Wolfgang Weikmann Vetter Pharma-Fertigung GmbH & Co. KG 24-25 February 2010, Tampa
Content 1. Manual Manual Vis Visual ual Ins Inspec pecti tion on (MVI (MVI)) – Basic requirements .
– overview
3. Quali Qualifi fica cati tion on Appro Approac ach h 1. PQ: Pre-test Pre-tests s / Consi Considera deration tions s 2. PQ 1: 1: Knap Knapp p test test (Tes (Testt kit) kit) .
4. Oper Operat atio iona nall Appr Approa oach ch 5. Concl nclusi usion 2
1
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
1. MVI – Basic requirements • Enclosed dedicated room • Incandescent Lamp (light intensity: 2000-3750 LUX) • Black & white background • Reject bin / Eject bin for measurements • Defect evaluation list (SOP) • Temperature monitoring of room • One product per room at a given time! • Inspection speed • uncontrolled units, rejects and good pieces! • Scheduled Eye Breaks
3
2. AVI - Machi ne Overview
Glass Barrel Remover (De-Trayer)
Inspection Machine
Glass Barrel Inserter (Re-Trayer)
Good Pieces
Product for inspection Ejection o f syring es 4
2
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
2. AVI – Machi ne Overview Unit 2 (TV 2a/3a & 2b/3b)
Unit 3 (TV 4/5)
Unit 4 (TV 6/7)
Glass Barrel
Closure Part
Stopper
Missing closure part Bent Needle Shield Fit of closure part/Total
Foreign particles Solution in rib Dirt/abrasion
Under- and Overfilling Empty syringe Dirt/Abrasion amage ev a on Scratches/Cracks zone 1 Airline over total length
Stopper position Upside-down (180°) Crooked stopper Double stopper
Closure Part
Unit 5 (TV 8/9) & 7 (TV 12/13) Solution
Dirt/Abrasion Damage/ deviation Broken bridge Pierced Needle Shield
Foreign particles
Unit 6 (TV 10/11) 0
OUTFEED INFEED
Solution Glass splinters
1 2
Unit 11 (HV) 3 4
Solution
Unit 1 (TV 1)
Leaking system
Glass Barrel Damaged finger rest Broken
Unit 8 (TV 14/15)
Unit 9 (CA) and 10 (OD)
Glass Barrel
Solution
Stopper
Scratches/Cracks zone 2
Discoloration, Turbidity
Missing stopper
5
2. AVI – Machine overview Eject 0
Eject 1
Eject 2
Eject 3
Glass Barrel Damaged finger rest Broken
Solution Discoloration, Turbidity
Solution Foreign particle
Solution Glass splinter n er- an over Empty syringe Leaked system
Stopper Foreign particle Solution in rib Dirt/ abrasion Damage/ deviation Stopper position Crooked stopper Double Stopper
Stopper Missing stopper
0
OUTFEED INFEED 1 2 3 4
Eject 4 After a machine failure or power break down, all remaining syringes in the machine are ejected here.
6
3
ng
Stopper Upside-down (180°) Glass Barrel Dirt/Abrasion Damage/Deviation Scratches/Cracks area 1 Scratches/Cracks area 2 Airline over total length Closure Part Dirt/Abrasion Damage/Deviation Broken bridge Pierced Needle Shield Missing closure part Bent Needle Shield Fit of the closure part/Total length Other defects Wrong primary packaging component
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3. Qualification / Validation Approach • Design Qualification
(DQ)
• • Operational Qualification
(OQ)
• Performance Qualification
(PQ)
• PQ 1: Knapp test with Test kit • P
2: Kna
test with 3 commercial lots
in this presentation, focus on PQ 7
3.1 PQ: Pre-tests / Considerations • Definition of Spinning speed • Definition of Ins ection area / windows • Air bubbles • Evaluation of different turbidity levels • Evaluation of different colors of the roduct solution • Detection level of foreign matter depending on different filling levels 8
4
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3.1 PQ: Pre-tests / Considerations • Light intensity • Regular checks • Definition of the max. holding time • Measures to be taken in case of decrease of light intensity – special maintenance / definition of acceptance criteria • Handling of exchange of lighting • Burn-in time of LED spare parts to reach acceptable stability 9
3.1 PQ: Pre-tests / Considerations • Heat-up of syringes during machine stop Definition of max. break time without removal of syringes • Definition of Defect categories (Assignment of minor, Major and Critical Creation of Batch Report)
• • Strategy for Manual Classification (Re-inspection) of Ejects 10
5
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3.1 PQ: Pre-tests / Considerations • Handling / Risk assessment in case of glass breakage at different locations within the machine • Implementation of effective Line Cleaning and Line Clearance
11
3.2 PQ 1: Knapp t est (Test kit)
• Creation of a product specific Test kit (Rejects + Good pieces) • 500 pieces in total comprising approx. 160 Rejects • Rejects selected from routine batches as far as possible • O tional: Usa e of standardized articles for better reproducibility in case of replacement due to destruction
12
6
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3.2 PQ 1: Knapp t est (Test kit)
• Performance of the Knapp test • MVI: 20 Visual Inspectors inspect each the test kit (500 pieces) / routine inspection conditions • AVI: Test kit (approx. 160 Rejects) are run 21 times in the „production mode“ of the AVI machine Aim: simulation of real production conditions as listed in the following:
13
3.2 PQ 1: Knapp t est (Test kit) •
AVI Efficiency Test 1. Reject Rate (RR) – Rejects 1. Aim: Test of each Inspection unit per defect (10 runs per defect) 2. AC: for each of the single defect categories: RR AVI ≥ RR MVI
2. False Reject Rate (FRR) – Good pieces . good pieces 2. AC: tbd. for each inspection unit
14
7
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3.2 PQ 1: Knapp t est (Test kit) •
AVI Laboratory Test Run 1. Reject Rate – Rejects 1. Testing each single Inspection unit 1. Aim: Test of each Inspection unit with all related defects (10 runs per defect) 2. AC: RR AVI ≥ RR MVI . 1. Aim: Test of all Inspection units with all defects (1 run with all defects) 2. AC: RR AVI ≥ RR MVI 15
3.2 PQ 1: Knapp t est (Test kit) 3. False Reject Rate – Good pieces 1. Aim: Test of all Inspection units with 2000 2. AC: tbd. for the whole machine
•
AVI Performance Run (Good pieces; at least Placebo) • of detection within 3 technical runs of the same lot ( ≥ 10.000 syringes recommended) • AC: tbd. dependent on Process Capability 16
8
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
3.3 PQ 2: Knapp test (3 batches)
Evaluation M2.1 + M3.1 = RR AVI M3.1 + M4.1 = RR MVI Comparison RR MVI vs. RR AVI 17
3.3 PQ 2: Knapp test (3 batches) • Acceptance criteria: • Different a
roaches are ossible e. .:
• #1: RR AVI ≥ RR MVI for all defect categories, not dependent on criticality of the defect • #2: Split into minor, Major and Critical: • Number of defects with (RR AVI ≥ RR MVI) ≥ (RR AVI < RR MVI) per Criticality Class
18
9
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
4. Operational App roach
19
4. Operational App roach 2. Manual Visual Classification
3. AQL (Good Pieces of Eject 0-4)
Rejects
- a ues accor ng o
Good Pieces (FRR)
Critical, Major, minor Rejects
Eject 1
Eject 2
Good Pieces (FRR)
Lot size = Sum of syringes of Ejects 0-4
Rejects
Sampling randomized of the Good Pieces (FRR) from Ejects 0-4:
Good Pieces (FRR)
n = 125 (Lot size less than 3.200)
Eject 3
Eject 4
Rejects
n=
Good Pieces (FRR)
o s ze e ween .
an
.
n = 315 (Lot size between 10.001 and 35.000)
Rejects
Good Pieces (FRR)
Good Pieces (FRR)
20
10
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
4. Operational App roach 2. Manual Visual Classification E ect 0
Eject 1
Eject 2
Eject 3
Eject 4
3. AQL
4. Batch Evaluation
(Good Pieces of Ejects 0-4)
Rejects Good Pieces (FRR)
Evaluation according to AVI Evaluation matrix
Rejects Good Pieces (FRR)
Rejects
minor:
X ≤ limit Batch Release X > limit Deviation/Measures
Major:
X ≤ limit Batch Release X > limit Deviation/Measures
Critical:
X ≤ limit Batch Release X > limit Deviation/Measures
Good Pieces (FRR)
Good Pieces (FRR)
Rejects
Rejects (total)
Good Pieces (FRR)
21
5. Conclusion • Main topics to be considered upfront: • Product characteristics • Evaluation strategy / Assignment of defects to Eject bins • Creation of the Test kit • Acceptable False Reject Rate • Re-Classification of Ejects • Performance of lighting • Preventive maintenance • Re-Qualification concept 22
11
ISPE Tampa Conference 22-25 February 2010 Tampa, Florida USA
Thank You! Wolfgang Weikmann Director Pharmaceutical Production / En ineerin Vetter Pharma-Fertigung GmbH & Co. KG Schuetzenstrasse 87 D - 88212 Ravensburg, Germany +49-(0)751-3700-2401
[email protected]
12